Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mary Stofan
Observed names:
Mary F. Stofan,
Stofan, Mary Frances
Institutions:
Rutgers, The State University of New Jersey,
Environmental and Occupational Health Sciences Institute
Observed institutions:
Rutgers, The State University of New Jersey,
Environmental and Occupational Health Sciences Institute
ORCID:
0000-0002-0435-9809
Observed ORCID:
0000-0002-0435-9809
OpenAlex ID:
A5038963878
Bile Acids and FXR: Novel Targets for Liver Diseases
2020
·
Mary Stofan
, Grace L. Guo
·
Frontiers in Medicine
·
230
PDF
Bile Acid Homeostasis in a Cholesterol 7α‐Hydroxylase and Sterol 27‐Hydroxylase Double Knockout Mouse Model
2019
·
Daniel Rizzolo
, Kyle Buckley
, et al.
·
Hepatology
·
87
Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency
2020
·
Mingxing Huang
, Bo Kong
, et al.
·
Laboratory Investigation
·
43
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR
2025
·
Zakiyah R Henry
, Syeda Maliha
, et al.
·
eGastroenterology
·
12
PDF
Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy
2024
·
Monica D. Chow
, Katherine Otersen
, et al.
·
Hepatology Communications
·
11
Deletion of hepatic FXR leads to more severe MASH development in female mice.
2025
·
Zakiyah R Henry
, Laura Armstrong
, et al.
·
PubMed Central
·
7
PDF
Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice
2025
·
Hong Shi
, Mary Stofan
, et al.
·
Drug Metabolism and Disposition
·
2
Show more works
View as search
Works count:
8
Citation count:
391
H-index:
6
I10-index:
5
Year
Topic
Type